nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PGR—migraine	0.892	1	CbGaD
Drospirenone—Thromboembolic event—Topiramate—migraine	0.00417	0.0555	CcSEcCtD
Drospirenone—Loss of libido—Gabapentin—migraine	0.00289	0.0385	CcSEcCtD
Drospirenone—Loss of libido—Topiramate—migraine	0.00243	0.0324	CcSEcCtD
Drospirenone—Cerebrovascular accident—Amitriptyline—migraine	0.00224	0.0299	CcSEcCtD
Drospirenone—Affect lability—Propranolol—migraine	0.00176	0.0235	CcSEcCtD
Drospirenone—Embolism—Topiramate—migraine	0.00175	0.0233	CcSEcCtD
Drospirenone—Mood swings—Propranolol—migraine	0.0017	0.0226	CcSEcCtD
Drospirenone—Cerebrovascular accident—Verapamil—migraine	0.00168	0.0224	CcSEcCtD
Drospirenone—NR3C2—ACE Inhibitor Pathway—ACE—migraine	0.00167	0.131	CbGpPWpGaD
Drospirenone—Acute coronary syndrome—Amitriptyline—migraine	0.00167	0.0223	CcSEcCtD
Drospirenone—Myocardial infarction—Amitriptyline—migraine	0.00166	0.0221	CcSEcCtD
Drospirenone—Breast pain—Gabapentin—migraine	0.00153	0.0204	CcSEcCtD
Drospirenone—Megestrol acetate—PGR—migraine	0.00151	0.27	CrCbGaD
Drospirenone—Depression—Propranolol—migraine	0.00138	0.0183	CcSEcCtD
Drospirenone—PGR—blood vessel—migraine	0.00133	0.0923	CbGeAlD
Drospirenone—Breast pain—Topiramate—migraine	0.00129	0.0171	CcSEcCtD
Drospirenone—Acute coronary syndrome—Verapamil—migraine	0.00125	0.0167	CcSEcCtD
Drospirenone—Myocardial infarction—Verapamil—migraine	0.00124	0.0166	CcSEcCtD
Drospirenone—Erythema multiforme—Propranolol—migraine	0.00117	0.0156	CcSEcCtD
Drospirenone—Affect lability—Valproic Acid—migraine	0.00115	0.0153	CcSEcCtD
Drospirenone—Mood swings—Valproic Acid—migraine	0.00111	0.0147	CcSEcCtD
Drospirenone—Mental disorder—Propranolol—migraine	0.00109	0.0145	CcSEcCtD
Drospirenone—Erythema multiforme—Verapamil—migraine	0.00108	0.0144	CcSEcCtD
Drospirenone—Cerebrovascular accident—Timolol—migraine	0.00106	0.0141	CcSEcCtD
Drospirenone—Breast disorder—Valproic Acid—migraine	0.00106	0.0141	CcSEcCtD
Drospirenone—Affect lability—Timolol—migraine	0.00102	0.0136	CcSEcCtD
Drospirenone—Cerebrovascular accident—Gabapentin—migraine	0.000988	0.0132	CcSEcCtD
Drospirenone—Mood swings—Timolol—migraine	0.000985	0.0131	CcSEcCtD
Drospirenone—Affect lability—Gabapentin—migraine	0.000953	0.0127	CcSEcCtD
Drospirenone—Migraine—Gabapentin—migraine	0.000953	0.0127	CcSEcCtD
Drospirenone—Breast disorder—Timolol—migraine	0.000939	0.0125	CcSEcCtD
Drospirenone—Spironolactone—PGR—migraine	0.000937	0.168	CrCbGaD
Drospirenone—Mood swings—Gabapentin—migraine	0.000917	0.0122	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Propranolol—migraine	0.000912	0.0121	CcSEcCtD
Drospirenone—Depression—Valproic Acid—migraine	0.000897	0.012	CcSEcCtD
Drospirenone—NR3C2—trigeminal ganglion—migraine	0.000881	0.0614	CbGeAlD
Drospirenone—Medroxyprogesterone Acetate—PGR—migraine	0.000878	0.158	CrCbGaD
Drospirenone—Breast disorder—Gabapentin—migraine	0.000875	0.0117	CcSEcCtD
Drospirenone—Norethindrone—PGR—migraine	0.00087	0.156	CrCbGaD
Drospirenone—Nervous system disorder—Propranolol—migraine	0.000863	0.0115	CcSEcCtD
Drospirenone—Skin disorder—Propranolol—migraine	0.000855	0.0114	CcSEcCtD
Drospirenone—Haemoglobin—Valproic Acid—migraine	0.000812	0.0108	CcSEcCtD
Drospirenone—Haemorrhage—Valproic Acid—migraine	0.000808	0.0108	CcSEcCtD
Drospirenone—Affect lability—Topiramate—migraine	0.000802	0.0107	CcSEcCtD
Drospirenone—Migraine—Topiramate—migraine	0.000802	0.0107	CcSEcCtD
Drospirenone—Depression—Timolol—migraine	0.000799	0.0106	CcSEcCtD
Drospirenone—NR3C2—brainstem—migraine	0.00078	0.0543	CbGeAlD
Drospirenone—Mood swings—Topiramate—migraine	0.000771	0.0103	CcSEcCtD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—PGR—migraine	0.000771	0.0604	CbGpPWpGaD
Drospirenone—Erythema multiforme—Valproic Acid—migraine	0.000764	0.0102	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Propranolol—migraine	0.00076	0.0101	CcSEcCtD
Drospirenone—Depression—Gabapentin—migraine	0.000744	0.00991	CcSEcCtD
Drospirenone—Breast disorder—Topiramate—migraine	0.000736	0.00981	CcSEcCtD
Drospirenone—Acute coronary syndrome—Gabapentin—migraine	0.000735	0.0098	CcSEcCtD
Drospirenone—Angiopathy—Valproic Acid—migraine	0.000733	0.00977	CcSEcCtD
Drospirenone—Myocardial infarction—Gabapentin—migraine	0.000731	0.00975	CcSEcCtD
Drospirenone—Mental disorder—Valproic Acid—migraine	0.000708	0.00943	CcSEcCtD
Drospirenone—Haemorrhage—Gabapentin—migraine	0.00067	0.00893	CcSEcCtD
Drospirenone—PTGS2—blood vessel—migraine	0.000662	0.0461	CbGeAlD
Drospirenone—Angiopathy—Timolol—migraine	0.000652	0.0087	CcSEcCtD
Drospirenone—Nausea—Amitriptyline—migraine	0.000642	0.00856	CcSEcCtD
Drospirenone—NR3C2—cardiovascular system—migraine	0.000636	0.0443	CbGeAlD
Drospirenone—Erythema multiforme—Gabapentin—migraine	0.000633	0.00844	CcSEcCtD
Drospirenone—Mental disorder—Timolol—migraine	0.00063	0.0084	CcSEcCtD
Drospirenone—Depression—Topiramate—migraine	0.000626	0.00834	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000595	0.00792	CcSEcCtD
Drospirenone—PGR—cardiovascular system—migraine	0.000591	0.0412	CbGeAlD
Drospirenone—Mental disorder—Gabapentin—migraine	0.000587	0.00782	CcSEcCtD
Drospirenone—Haemoglobin—Topiramate—migraine	0.000566	0.00755	CcSEcCtD
Drospirenone—Haemorrhage—Topiramate—migraine	0.000563	0.00751	CcSEcCtD
Drospirenone—Nervous system disorder—Valproic Acid—migraine	0.000563	0.0075	CcSEcCtD
Drospirenone—Skin disorder—Valproic Acid—migraine	0.000557	0.00743	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—ESR1—migraine	0.000554	0.0995	CrCbGaD
Drospirenone—Erythema multiforme—Topiramate—migraine	0.000533	0.0071	CcSEcCtD
Drospirenone—BCHE—trigeminal ganglion—migraine	0.000531	0.037	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000529	0.00705	CcSEcCtD
Drospirenone—Nausea—Propranolol—migraine	0.000523	0.00697	CcSEcCtD
Drospirenone—Angiopathy—Topiramate—migraine	0.000511	0.00681	CcSEcCtD
Drospirenone—Progesterone—PGR—migraine	0.000507	0.091	CrCbGaD
Drospirenone—Nervous system disorder—Timolol—migraine	0.000501	0.00668	CcSEcCtD
Drospirenone—Skin disorder—Timolol—migraine	0.000496	0.00661	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Valproic Acid—migraine	0.000495	0.0066	CcSEcCtD
Drospirenone—Mental disorder—Topiramate—migraine	0.000494	0.00658	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000493	0.00657	CcSEcCtD
Drospirenone—Nausea—Verapamil—migraine	0.000481	0.00641	CcSEcCtD
Drospirenone—AR—cardiovascular system—migraine	0.000471	0.0328	CbGeAlD
Drospirenone—BCHE—brainstem—migraine	0.00047	0.0327	CbGeAlD
Drospirenone—Nervous system disorder—Gabapentin—migraine	0.000467	0.00622	CcSEcCtD
Drospirenone—Skin disorder—Gabapentin—migraine	0.000462	0.00616	CcSEcCtD
Drospirenone—AR—Nuclear Receptors—PGR—migraine	0.000453	0.0355	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Timolol—migraine	0.000441	0.00588	CcSEcCtD
Drospirenone—NR3C2—head—migraine	0.000431	0.03	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000415	0.00553	CcSEcCtD
Drospirenone—NR3C2—Nuclear Receptor transcription pathway—ESR1—migraine	0.000412	0.0323	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Gabapentin—migraine	0.000411	0.00547	CcSEcCtD
Drospirenone—PTGS2—trigeminal ganglion—migraine	0.000409	0.0285	CbGeAlD
Drospirenone—NR3C2—nervous system—migraine	0.000409	0.0284	CbGeAlD
Drospirenone—PGR—head—migraine	0.000401	0.0279	CbGeAlD
Drospirenone—NR3C2—central nervous system—migraine	0.000393	0.0274	CbGeAlD
Drospirenone—Nervous system disorder—Topiramate—migraine	0.000393	0.00523	CcSEcCtD
Drospirenone—Skin disorder—Topiramate—migraine	0.000389	0.00518	CcSEcCtD
Drospirenone—NR3C2—cerebellum—migraine	0.000384	0.0268	CbGeAlD
Drospirenone—BCHE—cardiovascular system—migraine	0.000383	0.0267	CbGeAlD
Drospirenone—PGR—nervous system—migraine	0.00038	0.0264	CbGeAlD
Drospirenone—AR—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000367	0.0288	CbGpPWpGaD
Drospirenone—PGR—central nervous system—migraine	0.000366	0.0255	CbGeAlD
Drospirenone—AR—Nuclear Receptor transcription pathway—PGR—migraine	0.000358	0.028	CbGpPWpGaD
Drospirenone—PGR—cerebellum—migraine	0.000357	0.0249	CbGeAlD
Drospirenone—Gastrointestinal disorder—Topiramate—migraine	0.000346	0.00461	CcSEcCtD
Drospirenone—Nausea—Valproic Acid—migraine	0.000341	0.00454	CcSEcCtD
Drospirenone—Progesterone—ESR1—migraine	0.00032	0.0574	CrCbGaD
Drospirenone—AR—head—migraine	0.000319	0.0222	CbGeAlD
Drospirenone—PGR—Nuclear Receptors—ESR1—migraine	0.000317	0.0249	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—HTR3A—migraine	0.000312	0.0245	CbGpPWpGaD
Drospirenone—NR3C2—brain—migraine	0.000312	0.0217	CbGeAlD
Drospirenone—PGR—Nuclear signaling by ERBB4—ESR1—migraine	0.000311	0.0244	CbGpPWpGaD
Drospirenone—Nausea—Timolol—migraine	0.000303	0.00404	CcSEcCtD
Drospirenone—AR—nervous system—migraine	0.000303	0.0211	CbGeAlD
Drospirenone—PTGS2—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.0003	0.0235	CbGpPWpGaD
Drospirenone—PTGS2—cardiovascular system—migraine	0.000295	0.0206	CbGeAlD
Drospirenone—AR—central nervous system—migraine	0.000291	0.0203	CbGeAlD
Drospirenone—PGR—brain—migraine	0.00029	0.0202	CbGeAlD
Drospirenone—BCHE—Neuronal System—KCNK18—migraine	0.000285	0.0224	CbGpPWpGaD
Drospirenone—Nausea—Gabapentin—migraine	0.000283	0.00377	CcSEcCtD
Drospirenone—BCHE—head—migraine	0.00026	0.0181	CbGeAlD
Drospirenone—AR—Nongenotropic Androgen signaling—FOS—migraine	0.000256	0.0201	CbGpPWpGaD
Drospirenone—PGR—Nuclear Receptor transcription pathway—ESR1—migraine	0.000251	0.0196	CbGpPWpGaD
Drospirenone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.00025	0.0196	CbGpPWpGaD
Drospirenone—BCHE—nervous system—migraine	0.000246	0.0171	CbGeAlD
Drospirenone—AR—Nuclear Receptors—ESR1—migraine	0.000242	0.0189	CbGpPWpGaD
Drospirenone—PGR—Cellular roles of Anthrax toxin—TNF—migraine	0.000238	0.0187	CbGpPWpGaD
Drospirenone—Nausea—Topiramate—migraine	0.000238	0.00317	CcSEcCtD
Drospirenone—BCHE—central nervous system—migraine	0.000237	0.0165	CbGeAlD
Drospirenone—BCHE—cerebellum—migraine	0.000232	0.0161	CbGeAlD
Drospirenone—AR—brain—migraine	0.000231	0.0161	CbGeAlD
Drospirenone—AR—FOXA1 transcription factor network—ESR1—migraine	0.000215	0.0168	CbGpPWpGaD
Drospirenone—PGR—Validated nuclear estrogen receptor alpha network—ESR1—migraine	0.000209	0.0164	CbGpPWpGaD
Drospirenone—PTGS2—head—migraine	0.0002	0.0139	CbGeAlD
Drospirenone—AR—FOXA1 transcription factor network—FOS—migraine	0.000194	0.0152	CbGpPWpGaD
Drospirenone—AR—Nuclear Receptor transcription pathway—ESR1—migraine	0.000191	0.015	CbGpPWpGaD
Drospirenone—PTGS2—nervous system—migraine	0.00019	0.0132	CbGeAlD
Drospirenone—BCHE—brain—migraine	0.000188	0.0131	CbGeAlD
Drospirenone—PTGS2—central nervous system—migraine	0.000183	0.0127	CbGeAlD
Drospirenone—BCHE—Transmission across Chemical Synapses—CACNA1A—migraine	0.000182	0.0143	CbGpPWpGaD
Drospirenone—BCHE—Peptide hormone metabolism—ACE—migraine	0.000179	0.014	CbGpPWpGaD
Drospirenone—PTGS2—cerebellum—migraine	0.000178	0.0124	CbGeAlD
Drospirenone—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.000156	0.0122	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—HTR1A—migraine	0.000149	0.0116	CbGpPWpGaD
Drospirenone—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—migraine	0.000148	0.0116	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TAC1—migraine	0.000146	0.0115	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—NOTCH4—migraine	0.000146	0.0114	CbGpPWpGaD
Drospirenone—PTGS2—brain—migraine	0.000145	0.0101	CbGeAlD
Drospirenone—AR—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000143	0.0112	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—CACNA1A—migraine	0.000139	0.0109	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—PGR—migraine	0.000133	0.0104	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	0.000132	0.0103	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—NOTCH3—migraine	0.000124	0.0097	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000119	0.00935	CbGpPWpGaD
Drospirenone—AR—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	0.000119	0.00932	CbGpPWpGaD
Drospirenone—PTGS2—Overview of nanoparticle effects—TNF—migraine	0.000117	0.00919	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000111	0.0087	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—ESR1—migraine	0.000105	0.0082	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—BDNF—migraine	0.000104	0.00816	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.000101	0.00788	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—NOTCH4—migraine	8.87e-05	0.00695	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BDNF—migraine	8.86e-05	0.00694	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—HTR2A—migraine	8.8e-05	0.0069	CbGpPWpGaD
Drospirenone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—migraine	8.06e-05	0.00632	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—ESR1—migraine	8.02e-05	0.00628	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—MTHFR—migraine	7.99e-05	0.00626	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—NOTCH3—migraine	7.54e-05	0.00591	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—BDNF—migraine	7.49e-05	0.00587	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—ESR1—migraine	7.11e-05	0.00557	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NOTCH4—migraine	7.01e-05	0.00549	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NOTCH4—migraine	6.76e-05	0.00529	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—ESR1—migraine	6.64e-05	0.00521	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—PGR—migraine	6.41e-05	0.00502	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—PGR—migraine	6.18e-05	0.00484	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CALCRL—migraine	6.09e-05	0.00477	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RAMP1—migraine	6.09e-05	0.00477	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NOTCH3—migraine	5.96e-05	0.00467	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—TNF—migraine	5.78e-05	0.00453	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NOTCH3—migraine	5.75e-05	0.0045	CbGpPWpGaD
Drospirenone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	5.41e-05	0.00424	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—migraine	5.09e-05	0.00399	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—FOS—migraine	5.06e-05	0.00396	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR1D—migraine	4.42e-05	0.00346	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—ESR1—migraine	4.33e-05	0.00339	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH4—migraine	4.27e-05	0.00335	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR2B—migraine	4.11e-05	0.00322	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.82e-05	0.00299	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—migraine	3.78e-05	0.00297	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH3—migraine	3.63e-05	0.00284	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—LRP1—migraine	3.62e-05	0.00284	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CACNA1A—migraine	3.51e-05	0.00275	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—migraine	3.44e-05	0.0027	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—ESR1—migraine	3.42e-05	0.00268	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACE—migraine	3.38e-05	0.00265	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—ESR1—migraine	3.3e-05	0.00259	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH4—migraine	3.25e-05	0.00255	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—migraine	3.22e-05	0.00252	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PGR—migraine	2.98e-05	0.00233	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH4—migraine	2.78e-05	0.00218	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH3—migraine	2.77e-05	0.00217	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—migraine	2.72e-05	0.00213	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR1B—migraine	2.68e-05	0.0021	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR1A—migraine	2.58e-05	0.00202	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TAC1—migraine	2.54e-05	0.00199	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NPS—migraine	2.54e-05	0.00199	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR2C—migraine	2.49e-05	0.00195	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EDNRA—migraine	2.42e-05	0.0019	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CACNA1A—migraine	2.42e-05	0.00189	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH3—migraine	2.36e-05	0.00185	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CALCA—migraine	2.33e-05	0.00183	CbGpPWpGaD
Drospirenone—PTGS2—Disease—LRP1—migraine	2.26e-05	0.00177	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR7—migraine	2.18e-05	0.00171	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—ESR1—migraine	2.09e-05	0.00163	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFBR2—migraine	1.88e-05	0.00147	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.85e-05	0.00145	CbGpPWpGaD
Drospirenone—AR—Gene Expression—ESR1—migraine	1.59e-05	0.00124	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR2A—migraine	1.53e-05	0.0012	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALCA—migraine	1.46e-05	0.00114	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ESR1—migraine	1.36e-05	0.00106	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFBR2—migraine	1.18e-05	0.000921	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—MTHFR—migraine	1.16e-05	0.00091	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTHFR—migraine	9.54e-06	0.000748	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—MTHFR—migraine	7.99e-06	0.000626	CbGpPWpGaD
